News

In closing the 2015 UCSF Helen Diller Family Comprehensive Cancer Center Symposium, President Alan Ashworth, PhD, FRS, counted himself among those who might once have underappreciated the full potential of cancer immunotherapy. “But,” he declared, “it is clearly a field whose day has come.” He also

Christine Miaskowski, PhD, RN, the Sharon A. Lamb Endowed Chair in Symptom Management Research in the UCSF School of Nursing, is one of 19 nurse researchers being inducted into the International Nurse Researcher Hall of Fame by the Honor Society of Nursing, Sigma Theta Tau International (STTI)

A research team at UC San Francisco has won a five-year award of $14.1 million from the Patient-Centered Outcomes Research Institute (PCORI) to investigate whether a personalized approach to breast cancer screening is as safe and effective as annual mammograms. The project, called the WISDOM study

UC San Francisco chancellors emeriti J. Michael Bishop, MD, and Susan Desmond-Hellmann, MD, MPH, will appear next week in a Ken Burns-produced PBS documentary called “Cancer: The Emperor of All Maladies,” which is based on the Pulitzer Prize-winning book of the same name by Columbia University

A new study of acute lymphoblastic leukemia (ALL), a blood cancer that primarily affects young children, has revealed that the disease has two distinct subtypes, and provides preliminary evidence that about 13 percent of ALL cases may be successfully treated with targeted drugs that have proved

Tumor recurrence following a period of remission is the main cause of death in cancer. The ability of cancer cells to remain dormant during and following therapy, only to be reactivated at a later time, frequently with greater aggressiveness, is one of the least-understood aspects of the disease

For the second year in a row, UC San Francisco’s four schools topped the nation in federal biomedical research funding in their fields in 2014, with the graduate-level university as a whole receiving the most of any public recipient and second most overall in funds from the National Institutes of